Filing Flows › Harmony Biosciences Holdings (HRMY) › Recalls, complaints & regulation
Harmony Biosciences Holdings (HRMY): clinical trials
Harmony Biosciences Holdings (HRMY) beyond its filings: 6 active clinical trials.
Harmony Biosciences Holdings' latest quarter
Harmony Biosciences Holdings, Q3 2026: revenue $269M (+12% year over year), operating margin 20.2%, net earnings $48.2M, operating cash flow $76.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Harmony Biosciences Holdings have?
6 active studies on ClinicalTrials.gov, 4 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.